Drug Safety, ISoP offical journal

Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.

Drug Safety's structured program of peer-reviewed invited articles ensure comprehensive and critical coverage of all topics. The journal specializes in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

Benefit-risk assessments provide an in-depth review of adverse effect and efficacy data for a drug in a defined therapeutic area. High-quality original research focusing on the clinical implications of drug treatment safety issues is also published.

Drug Safety website

Discounted Drug Safety subscription

Get discounted Drug Safety subscription as ISoP member.

Guidelines for publication of adverse drug reaction reports in Drug Safety

Recommendations of a joint ISOP-ISPE group on the guidelines for the submission and publication of adverse drug reaction reports. This paper is published simultaneously in Drug Safety, ISOP's official journal, and in Pharmacoepidemiology and drug safety, ISPE's journal.

If ever you submit an adverse drug reaction report to a journal, please respect these recommendations, and cite this paper:

Guidelines for Submitting Adverse Event Reports for Publication (Drug Safety 2007)

The content of this paper represent's ISOP position, and not only its authors'.

For ISoP members only: you have received a link to the Drug Safety journal survey, please respond!

Click here for survey